Literature DB >> 8875325

Substance P and neurokinin A variations throughout the rat estrous cycle; comparison with ovariectomized and male rats: II. Trigeminal nucleus and cervical spinal cord.

P Duval1, V Lenoir, S Moussaoui, C Garret, B Kerdelhué.   

Abstract

Substance P and neurokinin A were assayed in the trigeminal nucleus and cervical spinal cord of 4-day cycling female, ovariectomized, and male rats. During the estrous cycle, levels were largely stable in the trigeminal nucleus. In ovariectomized rats, the levels differed from those on any day of the estrous cycle suggesting a weak effect of ovarian steroids. In males, the variations in the substance P and neurokinin A contents in the trigeminal nucleus were not similar to those in either cyclic or ovariectomized rats. The levels fluctuated substantially in the cervical spinal cord. During the first 3 days of the estrous cycle, the substance P and neurokinin A contents fell concomitant with the 17 beta-estradiol surge, suggesting a downregulation of substance P and neurokinin A contents by 17 beta-estradiol. Furthermore, on estrus, progesterone seemed to inhibit the accumulation of both neurokinins. Testosterone may stimulate accumulation of substance P and neurokinin A in the cervical spinal cord, with a marked circadian rhythm. These results are in favor of the neurokinin content of the spinal cord being regulated by the gonadal steroids. In the trigeminal nucleus, only testosterone has an effect.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8875325     DOI: 10.1002/(SICI)1097-4547(19960901)45:5<610::AID-JNR10>3.0.CO;2-2

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  7 in total

1.  Pharmacological characterization of the peripheral FAAH inhibitor URB937 in female rodents: interaction with the Abcg2 transporter in the blood-placenta barrier.

Authors:  G Moreno-Sanz; O Sasso; A Guijarro; O Oluyemi; R Bertorelli; A Reggiani; D Piomelli
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

2.  Does raloxifene treatment influence back pain and disability among postmenopausal women with osteoporosis?

Authors:  Georgios Papadokostakis; Pavlos Katonis; John Damilakis; Alexander Hadjipavlou
Journal:  Eur Spine J       Date:  2005-04-15       Impact factor: 3.134

3.  Estrogen in cycling rats alters gene expression in the temporomandibular joint, trigeminal ganglia and trigeminal subnucleus caudalis/upper cervical cord junction.

Authors:  Jyoti Puri; Larry L Bellinger; Phillip R Kramer
Journal:  J Cell Physiol       Date:  2011-12       Impact factor: 6.384

4.  Trigeminal electrophysiology: a 2 x 2 matrix model for differential diagnosis between temporomandibular disorders and orofacial pain.

Authors:  Gianni Frisardi; Giacomo Chessa; Gianfranco Sau; Flavio Frisardi
Journal:  BMC Musculoskelet Disord       Date:  2010-07-01       Impact factor: 2.362

Review 5.  Is fibromyalgia a neurologic disease?

Authors:  Laurence A Bradley; Nancy L McKendree-Smith; Graciela S Alarcón; Leanne R Cianfrini
Journal:  Curr Pain Headache Rep       Date:  2002-04

6.  Sexual Dimorphic Distribution of Hypothalamic Tachykinin1 Cells and Their Innervations to GnRH Neurons in the Zebrafish.

Authors:  Satoshi Ogawa; Priveena Nair Ramadasan; Rachel Anthonysamy; Ishwar S Parhar
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-03       Impact factor: 5.555

7.  Estrogen receptors involvement in intervertebral discogenic pain of the elderly women: colocalization and correlation with the expression of Substance P in nucleus pulposus.

Authors:  Xiao-Xing Song; Sheng Shi; Zhen Guo; Xin-Feng Li; Bu-Wei Yu
Journal:  Oncotarget       Date:  2017-06-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.